← SEC 公告列表 | ARAI SEC 公告 | Arrive AI Inc.(ARAI)

季報 季度報告 10-Q 2026-05-15

Arrive AI Inc. (ARAI) 2026年第一季10-Q 摘要

於 SEC 網站開啟原文

AI 繁中摘要

**Arrive AI Inc. (ARAI) 2026年第一季10-Q 摘要** - **申報類型**:10-Q(季度報告) - **財政季度**:2026年第一季(截至2026年3月31日) - **公司狀態**:早期科技公司,專注開發無人機、機械人及人類使用的智能郵箱系統。 **業績重點**: - 期內收入僅14,925美元(來自訂閱服務),去年同期零收入,反映商業化仍處於初步階段。 - 淨虧損擴大至637萬美元(去年同期198萬美元),主要因營運開支急增(一般行政開支421萬美元,研發開支35.7萬美元,銷售及市場推廣11.1萬美元)。 - 每股虧損0.18美元(去年同期0.07美元),加權平均股數3,617萬股。 **財務狀況**: - 截至2026年3月31日,現金及現金等價物567萬美元(2025年底210萬美元),短期投資280萬美元。 - 總資產1,549萬美元,總負債1,287萬美元,股東權益262萬美元(累計虧損3,512萬美元)。 - 期內通過發行可轉換票據(Convertible Note 4)籌集1,000萬美元,部分票據已轉換為普通股。 - 衍生負債公允價值變動帶來收益113萬美元,但可轉換票據轉換損失235萬美元。 **管理層展望與風險**: - 公司自成立以來持續虧損,管理層明確指出存在「持續經營重大疑慮」,依賴現有現金及短期投資(合共約847萬美元)以及Streeterville Capital LLC的可轉換票據融資(剩餘約1,900萬美元可用額度,但需滿足最低市值1億美元及賬面值400萬美元等條件)。 - 截至2026年5月12日,現金及短期投資約710萬美元。 - 研發及銷售開支顯著增加,反映公司正加速產品開發及市場拓展,但短期內收入覆蓋成本的能力有限。 -
展開英文正文
false
 Q1
 --12-31
 0001818274
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 0001818274
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 
 2026-05-15
 
 
 
 
 0001818274
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:CommonStockMember
 
 
 
 2024-12-31
 
 
 
 
 0001818274
 
 us-gaap:AdditionalPaidInCapitalMember
 
 
 
 2024-12-31
 
 
 
 
 0001818274
 
 ARAI:SubscriptionReceivableMember
 
 
 
 2024-12-31
 
 
 
 
 0001818274
 
 us-gaap:DeferredCompensationShareBasedPaymentsMember
 
 
 
 2024-12-31
 
 
 
 
 0001818274
 
 us-gaap:RetainedEarningsMember
 
 
 
 2024-12-31
 
 
 
 
 0001818274
 
 
 2024-12-31
 
 
 
 
 0001818274
 
 us-gaap:CommonStockMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:AdditionalPaidInCapitalMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:SubscriptionReceivableMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:DeferredCompensationShareBasedPaymentsMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:RetainedEarningsMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:CommonStockMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:AdditionalPaidInCapitalMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:SubscriptionReceivableMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:DeferredCompensationShareBasedPaymentsMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:RetainedEarningsMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:CommonStockMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:AdditionalPaidInCapitalMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:SubscriptionReceivableMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:DeferredCompensationShareBasedPaymentsMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:RetainedEarningsMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:CommonStockMember
 
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:AdditionalPaidInCapitalMember
 
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:SubscriptionReceivableMember
 
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:DeferredCompensationShareBasedPaymentsMember
 
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:RetainedEarningsMember
 
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:CommonStockMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:AdditionalPaidInCapitalMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:SubscriptionReceivableMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:DeferredCompensationShareBasedPaymentsMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:RetainedEarningsMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:VehiclesMember
 srt:MinimumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:VehiclesMember
 srt:MaximumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 
 2025-01-01
 2025-12-31
 
 
 
 
 0001818274
 
 
 2025-01-01
 2025-05-15
 
 
 
 
 0001818274
 
 us-gaap:ConvertibleDebtSecuritiesMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:ConvertibleDebtSecuritiesMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:WarrantMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:WarrantMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:EmployeeStockOptionMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:EmployeeStockOptionMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:RestrictedStockMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:RestrictedStockMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:SecuritiesPurchaseAgreementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:StreetervilleMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:StreetervilleMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 
 2026-05-12
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputExpectedTermMember
 ARAI:DerivativeOneMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputExpectedTermMember
 ARAI:DerivativeTwoMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputExpectedTermMember
 ARAI:DerivativeThreeMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputExpectedTermMember
 ARAI:DerivativeFourMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputSharePriceMember
 ARAI:DerivativeOneMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputSharePriceMember
 ARAI:DerivativeTwoMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputSharePriceMember
 ARAI:DerivativeThreeMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputSharePriceMember
 ARAI:DerivativeFourMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputOptionVolatilityMember
 ARAI:DerivativeOneMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputOptionVolatilityMember
 ARAI:DerivativeTwoMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputOptionVolatilityMember
 ARAI:DerivativeThreeMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputOptionVolatilityMember
 ARAI:DerivativeFourMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputRiskFreeInterestRateMember
 ARAI:DerivativeOneMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputRiskFreeInterestRateMember
 ARAI:DerivativeTwoMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputRiskFreeInterestRateMember
 ARAI:DerivativeThreeMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputRiskFreeInterestRateMember
 ARAI:DerivativeFourMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputDiscountRateMember
 ARAI:DerivativeOneMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputDiscountRateMember
 ARAI:DerivativeTwoMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputDiscountRateMember
 ARAI:DerivativeThreeMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputDiscountRateMember
 ARAI:DerivativeFourMember
 ARAI:InstrumentInceptionMeasurementMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputExpectedTermMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputExpectedTermMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputSharePriceMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputSharePriceMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputOptionVolatilityMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputOptionVolatilityMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputRiskFreeInterestRateMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputRiskFreeInterestRateMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputDiscountRateMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:MeasurementInputDiscountRateMember
 ARAI:DerivativeOneMember
 ARAI:RemeasureAtEachReportingMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputExpectedTermMember
 srt:MinimumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputExpectedTermMember
 srt:MaximumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputSharePriceMember
 srt:MinimumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputSharePriceMember
 srt:MaximumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputOptionVolatilityMember
 srt:MinimumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputOptionVolatilityMember
 srt:MaximumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputRiskFreeInterestRateMember
 srt:MinimumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputRiskFreeInterestRateMember
 srt:MaximumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputDiscountRateMember
 srt:MinimumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DerivativeFourMember
 us-gaap:MeasurementInputDiscountRateMember
 srt:MaximumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteOneMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteTwoMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteThreeMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteFourMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteOneMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteTwoMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteThreeMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteFourMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteOneMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteTwoMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteThreeMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteFourMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:VehiclesMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:VehiclesMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:EquipmentMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:EquipmentMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:LeaseholdImprovementsMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:LeaseholdImprovementsMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 us-gaap:ConstructionInProgressMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:ConstructionInProgressMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:OperatingLeaseAgreementMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:GroundRobotLeasesMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:PatentsMember
 srt:MinimumMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:PatentsMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:PatentsMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:PatentsMember
 ARAI:TwoThousandTwentySixMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:PrepaidPurchaseAgreementsMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:PrepaidPurchaseAgreementsMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:SecuritiesPurchaseAgreementMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:PreDeliverySharesMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:PreDeliverySharesMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:HostDebtInstrumentMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:NoteIssuanceSummaryMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteFourMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteFourMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteOneMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteTwoMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteThreeMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteFourMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteOneMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteTwoMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteThreeMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteOneMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteTwoMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:ConvertibleNoteThreeMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:VehicleNotePayableMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:VehicleNotePayableMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:DanielOTooleMember
 
 
 
 2020-06-01
 2020-06-01
 
 
 
 
 0001818274
 
 ARAI:DanielOTooleMember
 
 
 
 2020-06-01
 
 
 
 
 0001818274
 
 
 2020-06-01
 2020-06-01
 
 
 
 
 0001818274
 
 us-gaap:RestrictedStockMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:RestrictedStockMember
 ARAI:TwoThousandTwentyThreeEquityIncentivePlanMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:TwoThousandTwentyThreeEquityIncentivePlanMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:AccreditedInvestorMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:AccreditedInvestorMember
 
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:WarrantMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:OtherInvestorsMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:OtherInvestorsMember
 
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:EmployeesAndConsultantsMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:EmployeesAndConsultantsMember
 
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:ConsultantMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 ARAI:ConsultantMember
 
 
 
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:CommonStockMember
 
 
 
 2025-09-08
 
 
 
 
 0001818274
 
 ARAI:TwoThousandTwentyThreeIncentivePlanMember
 
 
 
 2023-04-27
 2023-04-27
 
 
 
 
 0001818274
 
 ARAI:TwoThousandTwentyThreeIncentivePlanMember
 
 
 
 2025-11-06
 2025-11-06
 
 
 
 
 0001818274
 
 ARAI:TwoThousandTwentyThreeIncentivePlanMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:RestrictedStockUnitsRSUMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:RestrictedStockUnitsRSUMember
 
 
 
 2025-01-01
 2025-03-31
 
 
 
 
 0001818274
 
 us-gaap:RestrictedStockUnitsRSUMember
 
 
 
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:RestrictedStockUnitsRSUMember
 
 
 
 2025-12-31
 
 
 
 
 0001818274
 
 
 2023-03-15
 
 
 
 
 0001818274
 
 
 2025-09-09
 2025-09-09
 
 
 
 
 0001818274
 
 country:US
 us-gaap:SalesRevenueNetMember
 us-gaap:GeographicConcentrationRiskMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 ARAI:OneCustomerMember
 us-gaap:SalesRevenueNetMember
 us-gaap:CustomerConcentrationRiskMember
 
 
 
 2026-01-01
 2026-03-31
 
 
 
 
 0001818274
 
 us-gaap:SubsequentEventMember
 ARAI:StreetervilleCapitalLLCMember
 
 
 
 2026-04-09
 2026-04-09
 
 
 
 
 0001818274
 
 us-gaap:SubsequentEventMember
 ARAI:StreetervilleCapitalLLCMember
 us-gaap:CommonStockMember
 
 
 
 2026-04-09
 2026-04-09
 
 
 
 
 0001818274
 
 us-gaap:SubsequentEventMember
 ARAI:StreetervilleCapitalLLCMember
 
 
 
 2026-04-16
 2026-04-16
 
 
 
 
 0001818274
 
 us-gaap:SubsequentEventMember
 ARAI:StreetervilleCapitalLLCMember
 us-gaap:CommonStockMember
 
 
 
 2026-04-16
 2026-04-16
 
 
 
 
 0001818274
 
 us-gaap:SubsequentEventMember
 ARAI:StreetervilleCapitalLLCMember
 
 
 
 2026-04-21
 2026-04-21
 
 
 
 
 0001818274
 
 us-gaap:SubsequentEventMember
 ARAI:StreetervilleCapitalLLCMember
 us-gaap:CommonStockMember
 
 
 
 2026-04-21
 2026-04-21
 
 
 
 
 0001818274
 
 us-gaap:SubsequentEventMember
 ARAI:StreetervilleCapitalLLCMember
 
 
 
 2026-04-02
 2026-05-15
 
 
 
 
 0001818274
 
 us-gaap:SubsequentEventMember
 ARAI:StreetervilleCapitalLLCMember
 us-gaap:CommonStockMember
 
 
 
 2026-04-02
 2026-05-15
 
 
 
 
 0001818274
 
 ARAI:MarkHammMember
 
 
 
 2025-09-22
 2025-09-22
 
 
 
 
 0001818274
 
 ARAI:MarkHammMember
 
 
 
 2025-09-22
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 xbrli:pure
 
 
 ARAI:Segments
 
 
 
 
 
 
 

 

 

 

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549

 

Form
10-Q

 

 
 ☒
 QUARTERLY
 REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 
 

For
the quarterly period ended March 31, 2026

 

or

 

 
 ☐
 TRANSITION
 REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 
 

For
the transition period from ____________ to ____________

 

Commission
File Number 001-42645

 

Arrive
AI Inc.

(Exact
name of registrant as specified in its charter)

 

 
 Delaware
  
 85-0935006

 
 (State
 or other jurisdiction

 of
 incorporation or organization)

  
 (I.R.S.
 Employer

 Identification
 No.)

 
 

 
 9100
 Fall View Drive

 Fishers,
 Indiana

  
 46037

 
 (Address
 of principal executive offices)
  
 (Zip
 code)

 
 

(463)
270-0092

(Registrant’s
telephone number, including area code)

 

Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to the filing requirements for at least the past 90 days.

 

 
 Yes
 ☒
  
 No 
     ☐

 
 

Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files).

 

 
 Yes
 ☒
  
 No 
     ☐

 
 

Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

 
 Large Accelerated Filer
 ☐
 Accelerated
 filer 
 ☐
 Non-accelerated filer 
 ☒

 
 Smaller Reporting Company
 ☒
 Emerging growth company
 ☒
  
  

 
 

If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

 
 Yes
 ☐
  
 No 
     ☒

 
 

Securities
registered pursuant to Section 12(b) of the Exchange Act:

 

 
 Title of
 each class
  
 Trading Symbol(s)
  
 Name of each
 exchange on which registered

 
 Common Stock par value $0.0002
 per share
  
 ARAI
  
 The Nasdaq Stock Market
 LLC

 
 

The
number of shares of the registrant’s common stock, par value $0.0002 per share, outstanding as of May 15, 2026, was 51,859,347.

 

 

 

  

  

 

 

TABLE
OF CONTENTS

 

 
  
  
 Page(s)

 
  
  
  

 
 PART I. FINANCIAL INFORMATION
  
 4

 
 Item 1. Financial Statements (unaudited)
  
 4

 
 Condensed Balance Sheets
  
 4

 
 Condensed Statements of Operations
  
 5

 
 Condensed Statements of Changes in Stockholders’ Equity
  
 6

 
 Condensed Statements of Cash Flows
  
 7

 
 Condensed Notes to Unaudited Financial Statements
  
 8-33

 
 Item 2. Management’s Discussion and Analysis of Financial Conditions and Results of Operations
  
 34

 
 Item 3. Quantitative and Qualitative Disclosures About Market Risk
  
 44

 
 Item 4. Controls and Procedures
  
 44

 
 PART II. OTHER INFORMATION
  
 44

 
 Item 1. Legal Proceedings
  
 44

 
 Item 1A. Risk Factors
  
 45

 
 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
  
 45

 
 Item 3. Defaults Upon Senior Securities
  
 45

 
 Item 4. Mine Safety Disclosures
  
 45

 
 Item 5. Other Information
  
 45

 
 Item 6. Exhibits
  
 45

 
 

 - 2 -

  

 

 

CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This
Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation
Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements largely
on our current expectations and projections about future events and financial trends impacting the financial condition of our business.
Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications
of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available
at the time those statements are made and/or management’s good faith belief as of that time with respect to future events and are
subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested
by the forward-looking statements.

 

Forward-looking
statements include all statements that are not historical facts. In some cases, you can identify forward-looking statements by terms
such as “may,” “will,” “should,” “could,” “would,” “expect,”
“intend,” “seek,” “plan,” “anticipate,” “believe,” “estimate,”
“project,” “predict,” “potential,” “might,” “forecast,” “continue,”
or the negative of those terms, and similar expressions and comparable terminology intended to reference future periods. Forward-looking
statements include, but are not limited to, statements about:

 

 
  
 ●
 our ability
 to protect and enforce our intellectual property protection and the scope and duration of such protection;

 
  
 ●
 our reliance on third parties,
 including suppliers, delivery platforms, brand sponsors, software providers and service providers;

 
  
 ●
 our ability to commercialize
 our products at a large scale;

 
  
 ●
 the competitive industry
 in which we operate, which is subject to rapid technological change;

 
  
 ●
 our ability to access the
 full funds under the existing convertible note payable facility;

 
  
 ●
 our ability to raise additional
 capital to develop our technology and scale our operations;

 
  
 ●
 developments and projections
 relating to our competitors and our industry;

 
  
 ●
 our ability to adequately
 control the costs associated with our operations;

 
  
 ●
 the impact of current and
 future laws and regulations, especially those related to autonomous delivery;

 
  
 ●
 potential cybersecurity
 risks to our operational systems, infrastructure, and integrated software by us or third-party vendors; and

 
  
 ●
 other risks and uncertainties,
 including those listed in our Annual Report on Form 10-K for the year ended December 31, 2025, including the factors described in
 the section entitled “Item 1A – Risk Factors.”

 
 

Should
one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ
significantly from those anticipated, believed, estimated, expected, intended or planned.

 

Factors
or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of
them. We cannot guarantee future results, levels of activity, performance or achievements. Accordingly, the forward-looking statements
in this Quarterly Report on Form 10-Q should not be regarded as representations that the results or conditions described in such statements
will occur or that our objectives and plans will be achieved, and we do not assume any responsibility for the accuracy or completeness
of any of these forward-looking statements.

 

 - 3 -

  

 

 

PART
I - FINANCIAL INFORMATION

 

Item
1. Financial Statements.

 

ARRIVE
AI INC.

 

CONDENSED
BALANCE SHEETS

 

 
   
 March 31, 2026  
 December 31, 2025 

 
   
 (Unaudited)  
  

 
   
    
   

 
 ASSETS 
     
    

 
   
     
    

 
 CURRENT ASSETS 
     
    

 
 Cash and cash equivalents 
 $5,667,553  
 $2,104,004 

 
 Investments at fair value 
  2,802,060  
  - 

 
 Accounts receivable, net of allowance 
  -  
  4,975 

 
 Prepaid expenses 
  280,102  
  189,878 

 
 Other current assets 
  12,325  
  12,325 

 
   
     
    

 
 Total current assets 
  8,762,040  
  2,311,182 

 
   
     
    

 
 OTHER ASSETS 
     
    

 
 Property and equipment, net 
  679,333  
  514,684 

 
 Right of use assets - operating leases 
  2,023,420  
  2,117,284 

 
 Patents, net of accumulated amortization of $3,120 and $2,603 
  271,580  
  272,097 

 
 Deferred offering costs 
  3,475,514  
  5,650,185 

 
 Other assets 
  279,187  
  65,633 

 
   
     
    

 
 Total other assets 
  6,729,034  
  8,619,883 

 
   
     
    

 
 TOTAL ASSETS 
 $15,491,074  
 $10,931,065 

 
   
     
    

 
 LIABILITIES AND STOCKHOLDERS’ EQUITY  
     
    

 
   
     
    

 
 CURRENT LIABILITIES 
     
    

 
 Accounts payable 
 $227,909  
 $183,993 

 
 Accrued expenses 
  1,490,720  
  538,234 

 
 Operating lease liability 
  408,345  
  392,950 

 
 Derivative liabilities 
  1,440,000  
  1,460,000 

 
 Convertible note payable, net of discount and debt issuance costs of $4,507,852 and $350,794, and $3,379,447 and $240,896, respectively 
  7,681,354  
  4,144,657 

 
 Note payable 
  8,336  
  9,140 

 
   
     
    

 
 Total current liabilities 
  11,256,664  
  6,728,974 

 
   
     
    

 
 LONG TERM LIABILITIES 
     
    

 
 Operating lease liability 
  1,616,553  
  1,725,073 

 
 Note payables, net of current portion 
  -  
  1,418 

 
   
     
    

 
 Total long term liabilities 
  1,616,553  
  1,726,491 

 
   
     
    

 
 Total liabilities 
  12,873,217  
  8,455,465 

 
   
     
    

 
 Commitments and Contingencies (See Note 16) 
     
    

 
   
     
    

 
 STOCKHOLDERS’ EQUITY  
     
    

 
 Common stock, $0.0002 par value, 200,000,000 authorized, 37,731,391 and 34,213,387 issued and outstanding at March 31, 2026 and December 31, 2025 
  7,545  
  6,841 

 
 Additional paid-in capital 
  37,834,831  
  31,215,698 

 
 Deferred compensation 
  (107,334) 
  - 

 
 Accumulated deficit 
  (35,117,185) 
  (28,746,939)

 
   
     
    

 
 Total stockholders’ equity  
  2,617,857  
  2,475,600 

 
  
     
    

 
 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  
 $15,491,074  
 $10,931,065 

 

 

See accompanying notes to these condensed financial statements.

 

 - 4 -

  

 

 

ARRIVE
AI INC.

 

CONDENSED
STATEMENTS OF OPERATIONS

(Unaudited)

 

 
   
 Three Months Ended  
 Three Months Ended 

 
   
 March 31, 2026  
 March 31, 2025 

 
   
    
   

 
 REVENUE 
 $14,925  
 $- 

 
   
     
    

 
 OPERATING EXPENSES 
     
    

 
 General and administrative 
  4,210,066  
  1,894,981 

 
 Research and development 
  357,073  
  91,263 

 
 Sales and marketing 
  111,350  
  7,661 

 
   
     
    

 
 Total operating expenses 
  4,678,489  
  1,993,905 

 
   
     
    

 
 OTHER INCOME (EXPENSES) 
     
    

 
 Interest expense 
  (361,870) 
  (1,175)

 
 Other income 
  177,789  
  16,915 

 
 Change in fair value of derivative liabilities 
  1,129,769  
  - 

 
 Accretion of debt discount 
  (250,969) 
  - 

 
 Loss on conversion of convertible notes payable 
  (2,345,613) 
  - 

 
 Realized gain on investments 
  446,324  
  - 

 
 Unrealized loss on investments 
  (502,112) 
  - 

 
   
     
    

 
 Total other income (expenses) 
  (1,706,682) 
  15,740 

 
   
     
    

 
 NET LOSS BEFORE TAXES 
  (6,370,246) 
  (1,978,165)

 
   
     
    

 
 PROVISION (BENEFIT) FOR INCOME TAXES 
  -  
  - 

 
   
     
    

 
 NET LOSS 
 $(6,370,246) 
 $(1,978,165)

 
   
     
    

 
 NET LOSS PER SHARE: 
     
    

 
 Basic and diluted 
 $(0.18) 
 $(0.07)

 
   
     
    

 
 WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING: 
     
    

 
 Basic and diluted 
  36,167,200  
  29,721,248 

 

 

See accompanying notes to these condensed financial statements.

 

 - 5 -

  

 

 

ARRIVE
AI INC.

 

CONDENSED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

 

For
the Three Months Ended March 31, 2026 and 2025 (Unaudited)

 

 
   
 Number of  
    
 Additional  
    
  
  
  
    
 Total 

 
   
 Common  
 Common  
 Paid-In  
 Subscription  
 Deferred
  
 Accumulated  
 Stockholders’ 

 
   
 Shares  
 Stock ($)  
 Capital ($)  
 Receivable ($)  
 Compensation ($)
  
 Deficit ($)  
 Equity (Deficit) ($) 

 
   
    
    
    
    
  
  
  
    
   

 
 BALANCE, JANUARY 1, 2025 
  26,620,905  
 $5,822  
 $14,984,561  
 $(53,003) 
 $
         -
  
 $(15,920,555) 
 $(983,175)

 
   
     
     
     
     
  
  
  
     
    

 
 Issuance of common stock and warrants for cash 
  96,346  
  19  
  677,390  
  40,219  
  
  
  
  -  
  717,628 

 
   
     
     
     
     
  
  
  
     
    

 
 Issuance of common stock for deferred offering costs 
  532,913  
  107  
  6,927,762  
  -  
  
  
  
  -  
  6,927,869 

 
   
     
     
     
     
  
  
  
     
    

 
 Stock-based compensation 
  84,874  
  17  
  1,348,228  
  -  
  
  
  
  -  
  1,348,245 

 
   
     
     
     
     
  
  
  
     
    

 
 Net loss 
  -  
  -  
  -  
  -  
  
 -
  
  (1,978,165) 
  (1,978,165)

 
   
     
     
     
     
  
  
  
     
    

 
 BALANCE, MARCH 31, 2025 
  27,335,038  
 $5,965  
 $23,937,941  
 $(12,784) 
 $
 -
  
 $(17,898,720) 
 $6,032,402 

 
   
     
     
     
     
  
  
  
     
    

 
 BALANCE, JANUARY 1, 2026 
  34,213,387  
 $6,841  
 $31,215,698  
 $-  
 $
 -
  
 $(28,746,939) 
 $2,475,600 

 
   
     
     
     
     
  
  
  
     
    

 
 Issuance of common stock for deferred compensation 
  118,343  
  24  
  160,976  
  -  
  
 (161,000
 )
  -  
  - 

 
   
     
     
     
     
  
  
  
     
    

 
 Issuance of common stock under stock plans 
  102,492  
  20  
  (20) 
  -  
  
 -
  
  -  
  - 

 
   
     
     
     
     
  
  
  
     
    

 
 Shares withheld for taxes upon vesting of restricted stock units 
  (32,308) 
  (6) 
  (25,743) 
  -  
  
 -
  
  -  
  (25,749)

 
   
     
     
     
     
  
  
  
     
    

 
 Issuance of common stock for the conversion of convertible notes payable 
  3,329,477  
  666  
  6,468,237  
  -  
  
 -
  
  -  
  6,468,903 

 
   
     
     
     
     
  
  
  
     
    

 
 Reclassification of derivative liabilities upon conversion of convertible notes payable 
  -  
  -  
  1,200,231  
  -  
  
 -
  
  -  
  1,200,231 

 
   
     
     
     
     
  
  
  
     
    

 
 Reclassification of deferred offering costs upon financing drawdown 
  -  
  -  
  (2,174,671) 
  -  
  
 -
  
  -  
  (2,174,671)

 
   
     
     
     
     
  
  
  
     
    

 
 Stock-based compensation 
  -  
  -  
  990,123  
  -  
  
 53,666
  
  -  
  1,043,789 

 
   
     
     
     
     
  
  
  
     
    

 
 Net loss 
  -  
  -  
  -  
  -  
  
  
  
  (6,370,246) 
  (6,370,246)

 
   
     
     
     
     
  
  
  
     
    

 
 BALANCE, MARCH 31, 2026 
  37,731,391  
  7,545  
  37,834,831  
  -  
  
 (107,334
 )
  (35,117,185) 
  2,617,857

 

 

 

See accompanying notes to these condensed financial statements.

 

 - 6 -

  

 

 

ARRIVE
AI INC.

 

CONDENSED
STATEMENTS OF CASH FLOWS

 

For
the Three Months Ended March 31, 2026 and 2025 (Unaudited)

 

 
   
 2026  
 2025 

 
 CASH FLOWS FROM OPERATING ACTIVITIES 
     
    

 
 Net loss 
 $(6,370,246) 
 $(1,978,165)

 
 Adjustments to reconcile net loss to net cash used in operating activities 
     
    

 
 Stock-based compensation 
  1,043,789  
  1,348,245 

 
 Depreciation and amortization 
  56,214  
  7,391 

 
 Credit loss expense 
  300  
  - 

 
 Operating lease liability - non-cash adjustment 
  739  
  - 

 
 Change in fair value of derivative liability 
  (1,129,769) 
  - 

 
 Loss on conversion of convertible notes payable 
  2,345,613  
  - 

 
 Accretion of discount on convertible note payable 
  250,969  
  - 

 
 Accretion of issuance costs on convertible note payable 
  119,018  
  - 

 
 Realized gain on investments 
  (446,324) 
  - 

 
 Unrealized loss on investments 
  502,112  
  - 

 
 Changes in operating assets and liabilities 
     
    

 
 (Increase) decrease in 
     
    

 
 Accounts receivable 
  4,675  
  - 

 
 Prepaid expenses 
  (90,224) 
  7,081 

 
 Other current assets 
  -  
  1,412 

 
 Other assets 
  (213,554) 
  - 

 
 Increase (decrease) in 
     
    

 
 Accounts payable 
  43,916  
  (66,262)

 
 Accrued expenses 
  952,486  
  133,627 

 
   
     
    

 
 Net cash used in operating activities 
  (2,930,286) 
  (546,671)

 
   
     
    

 
 CASH FLOWS FROM INVESTING ACTIVITIES 
     
    

 
 Capital expenditures 
  (220,346) 
  (2,832)

 
 Proceeds from sales of investments 
  8,893,827  
  - 

 
 Purchase of investments 
  (11,751,675) 
  - 

 
   
     
    

 
 Net cash used in investing activities 
  (3,078,194) 
  (2,832)

 
   
     
    

 
 CASH FLOWS FROM FINANCING ACTIVITIES 
     
    

 
 Proceeds from sale of common stock, net 
  -  
  420,753 

 
 Taxes paid for shares withheld upon vesting of restricted stock units 
  (25,749) 
  - 

 
 Proceeds from the exercise of warrants, net 
  -  
  296,875 

 
 Repayments of note payables 
  (2,222) 
  (2,075)

 
 Proceeds from issuance of convertible notes payable 
  10,000,000  
  - 

 
 Debt issuance costs 
  (400,000) 
  - 

 
   
     
    

 
 Net cash provided by financing activities 
  9,572,029  
  715,553 

 
   
     
    

 
 NET INCREASE IN CASH AND CASH EQUIVALENTS 
  3,563,549  
  166,050 

 
   
     
    

 
 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 
  2,104,004  
  129,318 

 
   
     
    

 
 CASH AND CASH EQUIVALENTS, END OF PERIOD 
 $5,667,553  
 $295,368 

 
   
     
    

 
 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION 
     
    

 
 Cash paid for: 
     
    

 
 Interest 
 $1,064  
 $321 

 
 Income taxes 
 $-  
 $- 

 
   
     
    

 
 SUPPLEMENTAL DISCLOSURE OF NONCASH INFORMATION 
     
    

 
 Common stock issued as payment of offering costs 
 $-  
 $6,927,869 

 
 Common stock issued for deferred compensation 
 $161,000  
 $- 

 
 Common stock issued for conversion of convertible notes payable 
 $6,468,903  
 $- 

 
 Derivative liabilities reclassified as additional paid-in capital upon conversion of convertible notes
 payable 
 $1,200,231  
 $- 

 
 Deferred offering costs recognized as additional paid-in capital upon financing drawdown 
 $2,174,671  
 $- 

 

 

See accompanying notes to these condensed financial statements.

 

 - 7 -

  

 

 

ARRIVE
AI INC.

 

CONDENSED
NOTES TO FINANCIAL STATEMENTS

 

NOTE
1 - NATURE OF OPERATIONS

 

Arrive
AI Inc. (the Company) was incorporated on April 30, 2020, in the State of Delaware as Dronedek Corporation. On July 27, 2023, Dronedek
Corporation changed its name to Arrive Technology Inc. On September 27, 2024, Arrive Technology Inc. changed its name to Arrive AI Inc.
The Company is an early-stage technology company with a focus on designing and implementing a commercially-viable smart mailbox for drone,
robotic and human package receiving and storage.

 

The
Company is subject to a number of risks similar to those of other companies of similar size in its industry, including, but not limited
to, the need for successful development of products, the need for additional capital (or financing) to fund operating losses, competition
from substitute products and services from larger companies, protection of proprietary technology, patent litigation, dependence on key
individuals, and risks associated with changes in information technology.

 

The
Company is an emerging growth company as the term is used in The Jumpstart Our Business Startups Act (JOBS Act), enacted on April 5,
2012 and has elected to comply with certain reduced public company reporting requirements.

 

NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES

 

Basis
of Presentation

 

The
accompanying financial statements of the Company have been prepared in accordance with accounting principles generally accepted in
the United States of America (“US GAAP”). These statements include all adjustments which management believes are
necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting policies
described in the Significant Accounting Policies included in the Company’s Annual Report on Form 10-K for the year ended
December 31, 2025 as originally filed with the Securities and Exchange Commission on April 15, 2026 (“the 2025 Annual
Report”). Certain financial information and footnote disclosures normally included in financial statements prepared in
accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to the rules
and regulations of the Securities and Exchange Commission, although the Company firmly believes that the accompanying disclosures
are adequate to make the information presented not misleading. The financial statements should be read in conjunction with the
financial statements and notes thereto included in the 2025 Annual Report. The interim operating results for the three months ended
March 31, 2026 may not be indicative of operating results expected for the full year.

 

Use
of Estimates

 

The
preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates.

 

Cash
and Cash Equivalents

 

The
Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash
equivalents, including money market accounts held at financial institutions. The Company had cash equivalents of $5,118,225 at March
31, 2026, and $0 at December 31, 2025.

 

Concentration
of Credit Risk

 

The
Company’s policy is to maintain its cash balances in accounts insured by the Federal Deposit Insurance Corporation (the “FDIC”)
or by the Securities Investor Protection Corporation (the “SIPC”). The Company may periodically have cash balances in financial
institutions in excess of FDIC and SIPC insurance limits. At March 31, 2026, and December 31, 2025, the Company had approximately $5,167,553
and $1,604,004 of cash in excess of insured limits, respectively.

 

 - 8 -

  

 

 

Management
believes that the Company is not exposed to any significant risk concerning its cash balances. To date, the Company has not recognized
any losses caused by uninsured balances.

 

Investments
at Fair Value

 

During
the three months ended March 31, 2026, the Company invested a portion of its excess cash in exchange-traded equity securities. The Company
accounts for these investments in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification
(“ASC”) ASC 321, Investments—Equity Securities. Equity securities with readily determinable fair values are
measured at fair value at each reporting date, with changes in fair value recognized in the statement of operations as unrealized gains
or losses. Realized gains and losses on the sale or disposition of equity securities are also recognized in the statement of operations
in the period of sale. The Company classifies the fair value of these securities within Level 1 of the fair value hierarchy established
under ASC 820, Fair Value Measurement, as the securities are exchange-traded with quoted prices in active markets. As of March
31, 2026 the company had equity securities. At December 31, 2025, the Company held no equity securities.

 

During
the three months ended March 31, 2026 and the year ended December 31, 2025, the Company wrote covered call options against its long
equity security positions to generate income from option premiums. Written call options are recognized as liabilities at fair value
in accordance with ASC 815, Derivatives and Hedging, and are remeasured at fair value at each reporting date. The Company
does not designate these instruments as accounting hedges; accordingly, changes in fair value are recognized in the statement of
operations within other income (expense). These instruments are classified within Level 1 of the fair value hierarchy, as they are
exchange-traded and valued using quoted market prices in active markets. Premiums received are reflected in the initial fair value
of the derivative liability and are subsequently recognized in earnings through changes in fair value over the life of the contract,
as the options are traded on recognized national exchanges with quoted prices in active markets. Option premium income received at
the time of writing is initially recorded as a liability representing the fair value of the written option and is recognized in
earnings upon settlement or expiration of the contract.

 

Accounts
Receivable and Allowance for Credit Losses

 

Accounts
receivable are customer obligations due under normal trade terms, which are typically due upon receipt of the invoice. Credit is
extended based on an evaluation of a customer’s financial condition and collateral is not required. Accounts receivable are
stated as amounts due from customers net of an allowance for credit losses. The Company recognizes an allowance for expected credit
losses at each balance sheet date. This estimate is derived from a review of the Company’s historical losses based on the
aging of receivables. Receivables with similar risk characteristics are pooled for the estimation of expected credit losses.
Management adjusts its historical estimate based on its assessment of current conditions, reasonable and supportable forecasts
regarding future events, and any other factors deemed relevant by the Company. At each reporting date, the Company updates its
estimate of expected credit losses to reflect any changes in credit risk since the receivable was initially recorded.

 

The
Company writes off receivables when there is information that indicates the debtor is facing significant financial difficulty and there
is no possibility of recovery. If any recoveries are made from any accounts previously written off, they will be recognized in earnings
in the year of recovery, in accordance with the entity’s accounting policy. The Company recorded an allowance for credit losses
at March 31, 2026 of $300. At December 31, 2025, management determined that substantially all outstanding receivables were fully collectible.
The Company did not incur material write-offs during the three months ended March 31, 2026 and year ended December 31, 2025.

 

Property
and Equipment

 

Property
and equipment is recorded at cost. Depreciation is computed using the straight-line method over the estimated useful life of the asset
ranging from 2two to five years. The cost of leasehold improvements is amortized over the lesser of the length of the related leases or
the estimated useful lives of the assets.

 

Maintenance
and repairs of property are charged to operations, and major improvements are capitalized. Upon retirement, sale, or other disposition
of property and equipment, the costs and accumulated depreciation are eliminated from the accounts, and any resulting gain or loss is
included in operations.

 

 - 9 -

  

 

 

Intangible
Assets – Patents

 

The
Company capitalizes external costs, such as filing fees, registration documentation, and attorney fees associated with the application
and issuance of patents. Amortization commences when the patent is granted and placed in service and is calculated on a straight-line
basis over the remaining legal life of the patent. Costs associated with pending applications are capitalized but not amortized until
issuance. Maintenance patent fees are paid to a government patent authority to maintain a granted patent in force. Some countries require
the payment of maintenance fees for pending patent applications; these are expensed as incurred. Maintenance fees paid after a patent
is granted are expensed, as these are considered ongoing costs to “maintain a patent.” The Company expenses costs associated
with maintaining and defending patents subsequent to issuance in the period incurred. The Company assesses the potential impairment of
all capitalized patent costs when events or changes in circumstances indicate that the carrying amount of the Company’s patent
portfolio may not be recoverable.

 

Impairment
of Long-Lived Assets

 

The
Company evaluates the recoverability of its long-lived assets in accordance with ASC 360, Property, Plant, and Equipment. The
Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an
asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to
future cashflows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are
considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds
the fair value of the assets.

 

The
Company has three types of long-lived assets: property and equipment, including vehicles, equipment, and leasehold improvements; construction-in-progress
(CIP), and intangible patent assets including those acquired by the acquisition of Airbox Technology in 2023. No impairments of long-lived
assets were considered necessary as of March 31, 2026 and December 31, 2025.

 

Revenue
Recognition

 

The
Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. The Company generates revenue from
consulting and implementation services and recurring subscription services for access to the Arrive Point network. The Company identifies
performance obligations in its contracts with customers, which generally consist of consulting services, installation services, and subscription
services. The transaction price is allocated to each distinct performance obligation based on relative standalone selling prices. Contracts
are typically short-term in nature and generally do not include significant variable consideration or financing components.

 

Consulting
and subscription services are recognized over time as the customer simultaneously receives and consumes the benefits of the services
in accordance with ASC 606-10-25-27(a). Revenue is recognized using an appropriate measure of progress that reflects the transfer of
control to the customer, generally based on time elapsed or services performed.

 

Installation
services are generally recognized at a point in time when control of the service is transferred to the customer, which typically occurs
upon completion of installation and customer acceptance, if applicable.

 

Contract
Balances

 

The
timing of revenue recognition, billings and cash collections results in billed accounts receivable, and, when applicable, unbilled receivables
(contract assets), and customer advances and deposits (contract liabilities) on the balance sheet. The Company may request advances or
deposits from customers before revenue is recognized, which results in contract liabilities. These contract liabilities are released
as the performance obligations are satisfied. As disclosed in NOTE 3, the Company did not have any contract assets or contract liabilities
recorded on the balance sheet as of March 31, 2026 and December 31, 2025.

 

 - 10 -

  

 

 

Leases

 

The
Company accounts for leases in accordance with ASC 842, Leases. The Company determines whether an arrangement is a lease at contract
inception. The Company classifies leases as operating or finance leases at commencement; however, all of the Company’s leases are
currently classified as operating leases. Operating leases are included in “Right-of-use assets – operating leases”
and “Operating lease liabilities” in the Company’s balance sheets.

 

Right-of-use
(“ROU”) assets represent the Company’s right to use the underlying asset for the lease term, and lease liabilities
represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities
are recognized at the commencement date based on the present value of lease payments over the lease term. Lease payments included in
the measurement o